Is your treatment plan a prescription or a collaboration? DBSA is changing the dialogue between mental health practitioners and consumers and we invite you to be a part of it.

On Monday, November 12, 2012, DBSA joined forces with the International Society for Bipolar Disorder (ISBD) and the Collaborative Care Initiative (CCI) to host a live and simultaneous web-streamed panel discussion about enhancing collaborative care.

Instead of individuals simply following a plan as outlined by a mental health professional, this panel of consumers and clinicians discussed the idea of concordance: clinicians working together with consumers to jointly develop and agree on a treatment plan that addresses the goals and limitations of each individual. Learn about building better relationships with mental healthcare providers and accomplishing your unique goals at Concordance 2012.


Concordance 2012 Panel

Dr. Gary Sachs, Moderator

Associate Clinical Professor in Psychiatry at Harvard Medical School and a psychiatrist at the Massachusetts General Hospital (MGH), Dr. Gary Sachs is the founding director of the MGH Bipolar Clinic and Research Program. Dr. Sachs served as the principal investigator of the National Institute of Mental Health (NIHM) Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), the largest treatment study ever conducted for bipolar disorder. Dr. Sachs serves on the DBSA Scientific Advisory Board and chairs the scientific advisory board for the National Alliance on Mental Illness (NAMI). Dr Sachs is recognized as a top doctor by US News and World Report. As a recipient of an NIH Small Business Innovative Research Grant, he founded Concordant Rater Systems and obtained patent for methods used to improve endpoint reliability in clinical trials. He currently focuses his work on clinical trial methodology, innovative approaches to clinical practice, and patient-centered research.

Dr. Mark Frye, Panelist

Dr. Mark Frye is the chair of the Department of Psychiatry & Psychology at the Mayo Clinic. He completed a research fellowship at the National Institute of Mental Health (NIMH), where his research focused on the neurobiology of depression and bipolar disorder. Formerly the director of the UCLA Bipolar Disorder Research Program, he currently directs the Mayo Clinic Depression Center. His clinical interests are in mood disorders (bipolar disorder, treatment resistant depression) with a research focus in clinical trials, pharmacogenomics, and brain imaging. He has received numerous honors and awards both as an educator and researcher, including the 2011 Mogens Schou Award for Education from the ISBD and the Gerald Klerman Young Investigator Award from DBSA. Dr. Frye serves on the DBSA Scientific Advisory Board and is the vice president of global outreach for ISBD.

Lucy Ingram, Panelist

Lucy Ingram currently works as a peer specialist at a mental health agency outside of Boston, where she supports individuals with mental illness transition into the community and move forward in their recovery. She earned her BA in psychology from Connecticut College in 2011. During her sophomore year of college, Lucy was diagnosed with bipolar disorder. As a college student with mental illness, Lucy faced many challenges and observed a lack of open, positive discussion on campus about mental health issues. During her senior year, she co-founded a chapter of Active Minds, a student-run organization dedicated to reducing stigma surrounding mental illness and educating the college community. Lucy was motivated to become a peer specialist and be involved in the peer movement so that she could take her lived experience with mental illness and utilize it to help individuals, families, and communities realize that recovery is possible.

Lucinda Jewell, Ed. M., Panelist

Chair of the Depression and Bipolar Support Alliance Board of Directors, Lucinda Jewell, Ed. M. is the former President of DBSA Boston and still serves on the board there. Previously, she was co-founder of the Boston Book Review, a literary review modeled on the Times Literary Supplement. She earned her Ed. M in Human Development and Psychology from Harvard and taught ESL in China. Since being diagnosed with bipolar disorder in 1995, she has been a tireless educator and advocate for transforming the conversation for mental health from danger and drain to one of resiliencies and contribution. She lives with her daughter in Cambridge, Massachusetts.

Louisa Sylvia, PhD, Panelist

Assistant Professor at Harvard Medical School, Dr. Louisa Sylvia is a staff psychologist and Associate Director of Psychology at Bipolar Clinic and Research Program at Massachusetts General Hospital. Her major research interests are developing psychosocial interventions for bipolar disorder, particularly improving the management of exercise, nutrition, and sleep in this clinical population. She was recently awarded a K23 career development grant from the National Institute of Mental Health to develop Nutrition/diet, Exercise, and Wellness Treatment (NEW Tx) for bipolar disorder. Dr. Sylvia is also the Director of Clinical Operations of the Bipolar Trials Network. A trained cognitive-behavioral therapist, Dr. Sylvia maintains an active caseload of individuals with bipolar disorder. In 2006, she received a commendation of excellence from the faculty at Temple University for her work investigating the role of lifestyle regularity in individuals at risk for developing bipolar disorder.

Special Thanks

Marketing and promotions for this event are supported by a charitable contribution from Janssen Pharmaceuticals, Inc.

Concordance 2012 is supported in part by an independent educational grant from Merck & Co., Inc.

This program is funded in part by a contribution from Lilly, USA, LLC, which had no control over its content. No personally-identifiable information regarding attendees is provided to any grant supporters.

Additional support provided by Marylou Selo.